Skip to main content

Research Repository

Advanced Search

Outputs (118)

Comparative analysis of cardiogenic shock outcomes in acute myocardial infarction with polyvascular disease (2024)
Journal Article
Gatuz, M. V., Abu-Fanne, R., Abramov, D., Barel, M., Mamas, M. A., Roguin, A., & Kobo, O. (2024). Comparative analysis of cardiogenic shock outcomes in acute myocardial infarction with polyvascular disease. American Heart Journal Plus: Cardiology Research and Practice, 46, Article 100452. https://doi.org/10.1016/j.ahjo.2024.100452

Background
Cardiogenic shock (CS) is the leading cause of mortality in acute myocardial infarction (AMI) patients, especially in those with vascular disease. This study aimed to assess the association between extent of polyvascular disease and the i... Read More about Comparative analysis of cardiogenic shock outcomes in acute myocardial infarction with polyvascular disease.

Temporal Trends of Infant Mortality Secondary to Congenital Heart Disease: National CDC Cohort Analysis (1999–2020) (2024)
Journal Article
Chobufo, M., Ali, S., Taha, A., Duhan, S., Patel, N., Gonuguntla, K., Ludhwani, D., Thyagaturu, H., Keisham, B., Shaik, A., Alharbi, A., Sattar, Y., Mamas, M., Kohli, U., & Balla, S. (2024). Temporal Trends of Infant Mortality Secondary to Congenital Heart Disease: National CDC Cohort Analysis (1999–2020). Birth Defects Research, 116(9), 1-8. https://doi.org/10.1002/bdr2.2398

Background
Infant mortality continues to be a significant problem for patients with congenital heart disease (CHD). Limited data exist on the recent trends of mortality in infants with CHD.

Methods
The CDC WONDER (Centers for Disease Control and... Read More about Temporal Trends of Infant Mortality Secondary to Congenital Heart Disease: National CDC Cohort Analysis (1999–2020).

Post-COVID changes and disparities in cardiovascular mortality rates in the United States (2024)
Journal Article
Kobo, O., Misra, S., Banerjee, A., Rutter, M. K., Khunti, K., & Mamas, M. A. (2024). Post-COVID changes and disparities in cardiovascular mortality rates in the United States. Preventive Medicine Reports, 46, Article 102876. https://doi.org/10.1016/j.pmedr.2024.102876

Introduction
The COVID-19 pandemic disrupted healthcare delivery and increased cardiovascular morbidity and mortality. This study assesses whether cardiovascular mortality rates in the US have recovered post-pandemic and examines the equity of this... Read More about Post-COVID changes and disparities in cardiovascular mortality rates in the United States.

Diabetes and Its Impact on Cardiogenic Shock Outcomes in Acute Myocardial Infarction with Polyvascular Disease: A Comparative Analysis (2024)
Journal Article
Gatuz, M. V., Abu-Fanne, R., Abramov, D., Mamas, M. A., Roguin, A., & Kobo, O. (in press). Diabetes and Its Impact on Cardiogenic Shock Outcomes in Acute Myocardial Infarction with Polyvascular Disease: A Comparative Analysis. Biomedicines, 12(8), Article 1900. https://doi.org/10.3390/biomedicines12081900

Background: Diabetes mellitus (DM) significantly impacts cardiovascular outcomes, particularly in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS). The presence of polyvascular disease further complicates the prog... Read More about Diabetes and Its Impact on Cardiogenic Shock Outcomes in Acute Myocardial Infarction with Polyvascular Disease: A Comparative Analysis.

Impact of Chronic Kidney Disease on the Processes of Care and Long-Term Mortality of Non-ST-Segment-Elevation Myocardial Infarction: A Nationwide Cohort Study and Long-Term Follow-Up. (2024)
Journal Article
Weight, N., Moledina, S., Ullah, M., Wijeysundera, H. C., Davies, S., Chew, N. W. S., Lawson, C., Khan, S. U., Gale, C. P., Rashid, M., & Mamas, M. A. (in press). Impact of Chronic Kidney Disease on the Processes of Care and Long-Term Mortality of Non-ST-Segment-Elevation Myocardial Infarction: A Nationwide Cohort Study and Long-Term Follow-Up. Journal of the American Heart Association, 13(16), Article e032671. https://doi.org/10.1161/JAHA.123.032671

A growing population of patients with chronic kidney disease (CKD) presents with non-ST-segment-elevation myocardial infarction, although little is known about their longer-term mortality. Using the MINAP (Myocardial Ischaemia National Audit Project)... Read More about Impact of Chronic Kidney Disease on the Processes of Care and Long-Term Mortality of Non-ST-Segment-Elevation Myocardial Infarction: A Nationwide Cohort Study and Long-Term Follow-Up..

2236 Emergency department attendance stratified by cause and frailty status: a national cohort study of over 155 million patients (2024)
Presentation / Conference Contribution
Sokhal, B., Matetić, A., Protheroe, J., Helliwell, T., Myint, P., Paul, T., Mallen, C., & Mamas, M. 2236 Emergency department attendance stratified by cause and frailty status: a national cohort study of over 155 million patients. Presented at British Geriatrics Society Spring 2024 Meeting (22 -24 May 2024), Vox, Birmingham, UK & Online

Introduction Data are limited on whether the causes of Emergency Department (ED) attendance and clinical outcomes vary by frailty status. Methods Using data from the Nationwide Emergency Department Sample, all ED attendances from 2016 to 2018 were st... Read More about 2236 Emergency department attendance stratified by cause and frailty status: a national cohort study of over 155 million patients.

EXPRESS: Dual Versus Triple Antithrombotic Therapy in Atrial Fibrillation and Acute Coronary Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials. (2024)
Journal Article
Sainbayar, E., Pham, H. N., Olson, A., Ibrahim, R., Grewal, H., Salih, M., Mamas, M. A., Lee, K., & Mamas, M. A. (in press). EXPRESS: Dual Versus Triple Antithrombotic Therapy in Atrial Fibrillation and Acute Coronary Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials. Journal of Investigative Medicine, https://doi.org/10.1177/10815589241270640

Antithrombotic treatment in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS) poses a dilemma. We compared outcomes of dual thrombotic therapy (DAT) (direct oral anticoagulants [DOACs]/warfarin + antiplatelets) versus triple an... Read More about EXPRESS: Dual Versus Triple Antithrombotic Therapy in Atrial Fibrillation and Acute Coronary Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials..

The prognostic value of mean platelet volume in patients with coronary artery disease: An updated systematic review with meta-analyses. (2024)
Journal Article
Galimzhanov, A., Tun, H. N., Sabitov, Y., Perone, F., Kursat, T. M., Tenekecioglu, E., & Mamas, M. A. (in press). The prognostic value of mean platelet volume in patients with coronary artery disease: An updated systematic review with meta-analyses. European Journal of Clinical Investigation, Article e14295. https://doi.org/10.1111/eci.14295

Mean platelet volume (MPV) is a widely available laboratory index, however its prognostic significance in patients with coronary artery disease (CAD) is still unclear. We intended to investigate and pool the evidence on the prognostic utility of admi... Read More about The prognostic value of mean platelet volume in patients with coronary artery disease: An updated systematic review with meta-analyses..

30-Day unplanned readmission rates, causes and outcomes of patients hospitalized for acute coronary syndrome based on the trial participation status. (2024)
Journal Article
Matetic, A., Kuchtaruk, A., Siudak, Z., Ullah, W., Elbadawi, A., Elgendy, I. Y., Zaman, S., Bang, V., Rao, S., Bagur, R., & Mamas, M. A. (in press). 30-Day unplanned readmission rates, causes and outcomes of patients hospitalized for acute coronary syndrome based on the trial participation status. Cardiovascular Revascularization Medicine, https://doi.org/10.1016/j.carrev.2024.07.023

This study aimed to investigate the association between index trial participation status and 30-day unplanned readmission rates, causes, and outcomes in acute coronary syndrome (ACS) patients. The National Readmission Database was analysed for all in... Read More about 30-Day unplanned readmission rates, causes and outcomes of patients hospitalized for acute coronary syndrome based on the trial participation status..